Plantar FasciitisNCT07057505
Pain and Fascia Thickness After Steroid Injection in Plantar Fasciitis
An observational study of Plantar Fasciitis, run by Istanbul Physical Medicine Rehabilitation Training and Research Hospital at 1 site in Turkey (Türkiye).
Trial summary
The aim of this study is to evaluate the effects of local corticosteroid injection on pain, foot function index, and plantar fascia thickness in patients clinically diagnosed with plantar fasciitis, and to determine whether local corticosteroid injection is an appropriate treatment option for plantar fasciitis. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Plantar Fasciitis
- Type of treatment
- Injection or infusion
- How many people
- 33 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Aug 2025to 20 Dec 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: 33 patients who volunteered to participate in the study and applied to the Physical Medicine and Rehabilitation Clinic of the SBÜ Istanbul Physical Therapy and Rehabilitation Education and Research Hospital and were diagnosed with plantar fasciitis clinically and received local corticosteroid injections will be included in the study.
Who may be able to join
- Patients who were clinically diagnosed with plantar fasciitis and received corticosteroid injections
Who cannot join
- Pregnancy
- Patients who have had more than one corticosteroid injection in the last 6 months
- Patients with systemic inflammatory diseases
- Patients who have previously undergone surgery in the heel area
- Patients with a history of local trauma
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)1 site
Istanbul physical therapy rehabilitation training and research hospital
Istanbul, Bahçelievler, 34188
Mehmet Tekne, MD, +90 541 547 33 23, mehmettekne23@gmail.com
About this study
Official title: Assesment of Pain, Foot Function, and Ultrasonographic Evaluation of Plantar Fascia Thickness in Patients Treated With Local Corticosteroid Injection for Plantar Fasciitis
The aim of this study is to evaluate the effects of local corticosteroid injection on pain, foot function index, and plantar fascia thickness in patients clinically diagnosed with plantar fasciitis, and to determine whether local corticosteroid injection is an appropriate treatment option for plantar fasciitis. For this purpose, the study plans to assess plantar fascia thickness using ultrasonography, evaluate pain using the Visual Analog Scale (VAS), and investigate the impact on daily living activities in patients who have been clinically diagnosed with plantar fasciitis and treated with local corticosteroid injections.
- Conditions
- Plantar Fasciitis
- Keywords
- plantar fasciitis, plantar fascia thickness, ultrasonographic evaluation, injection
- Medical subject headings
- Fasciitis, Plantar
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Plantar Fasciitis Patients with Corticosteroid Injection | The study cohort consists of patients clinically diagnosed with plantar fasciitis who have received local corticosteroid injections as part of their treatment. These patients were selected based on clinical criteria for plantar fasciitis and have undergone at least one ultrasound-guided corticosteroid injection targeting the affected plantar fascia. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Plantar fascia thickness
Plantar fascia thickness measured by ultrasound
Measured: The thickness measurement will be evaluated immediately after the injection and 1 month after the injection.
Pain score
Pain score assessed with a visual analog scale between 0 and 100
Measured: Pain will be assessed with a visual analog scale immediately after injection and 1 month later
Secondary outcomes (1)
Foot functions
Foot functions will be assessed immediately after injection and 1 month after injection with the foot function index.
Measured: Foot functions will be assessed immediately after injection and 1 month after injection with the foot function index.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Jul 2025
- Study start1 Aug 2025 (estimated)
- Primary completion20 Nov 2025 (estimated)
- Study completion20 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Plantar FasciitisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 33 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Istanbul Physical Medicine Rehabilitation Training and Research Hospital
- Sponsor type
- Other government
- Responsible party
- Principal investigator, mehmet tekne, Istanbul Physical Medicine Rehabilitation Training and Research Hospital
- Investigators
- Mehmet Tekne, Resident Doctor, Principal investigator, Istanbul physical therapy rehabilitation training and research hospitalNurdan Paker, Professor Doctor, Study director, Istanbul physical therapy rehabilitation training and research hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07057505
- Sponsor's protocol ID
- 2025-41
- Status last verified
- Jun 2025
- First submitted
- 7 Jul 2025
- Last updated
- 18 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
''Yalıman A, Şen Eİ, Eskiyurt N, Budiman-Mak E. Ayak Fonksiyon İndeksi'nin Plantar Fasiitli Hastalarda Türkçe'ye Çeviri ve Adaptasyonu. Türk Fiz Tıp Rehab Derg 2014;60:212-22''
Aggarwal P, Jirankali V, Garg SK. Evaluation of plantar fascia using high-resolution ultrasonography in clinically diagnosed cases of plantar fasciitis. Pol J Radiol. 2020 Jul 24;85:e375-e380. doi: 10.5114/pjr.2020.97955. eCollection 2020.
PubMed 32817771McMillan AM, Landorf KB, Gilheany MF, Bird AR, Morrow AD, Menz HB. Ultrasound guided corticosteroid injection for plantar fasciitis: randomised controlled trial. BMJ. 2012 May 22;344:e3260. doi: 10.1136/bmj.e3260.
PubMed 22619193
Study at a glance
From the registry record, last updated by the sponsor on 18 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Assesment of Pain, Foot Function, and Ultrasonographic Evaluation of Plantar Fascia Thickness in Patients Treated With Local Corticosteroid Injection for Plantar Fasciitis
- ClinicalTrials.gov ID
- NCT07057505
- Acronym / sponsor ID
- 2025-41
- Conditions
- Plantar Fasciitis
- Keywords
- plantar fasciitis, plantar fascia thickness, ultrasonographic evaluation, injection
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 33 participants (estimated)
- Lead sponsor
- Istanbul Physical Medicine Rehabilitation Training and Research HospitalOther government
- Study start
- 1 Aug 2025 (estimated)
- Primary completion
- 20 Nov 2025 (estimated)
- Study completion
- 20 Dec 2025 (estimated)
- First posted
- 10 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to evaluate the effects of local corticosteroid injection on pain, foot function index, and plantar fascia thickness in patients clinically diagnosed with plantar fasciitis, and to determine whether local corticosteroid injection is an appropriate treatment option for plantar fasciitis. For this purpose, the study plans to assess plantar fascia thickness using ultrasonography, evaluate pain using the Visual Analog Scale (VAS), and investigate the impact on daily living activities in patients who have been clinically diagnosed with plantar fasciitis and treated with local corticosteroid injections.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Plantar Fasciitis Patients with Corticosteroid Injection | – | –The study cohort consists of patients clinically diagnosed with plantar fasciitis who have received local corticosteroid injections as part of their treatment. These patients were selected based on clinical criteria for plantar fasciitis and have undergone at least one ultrasound-guided corticosteroid injection targeting the affected plantar fascia. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- 33 patients who volunteered to participate in the study and applied to the Physical Medicine and Rehabilitation Clinic of the SBÜ Istanbul Physical Therapy and Rehabilitation Education and Research Hospital and were diagnosed with plantar fasciitis clinically and received local corticosteroid injections will be included in the study.
Key inclusion criteria (1 listed)
- Patients who were clinically diagnosed with plantar fasciitis and received corticosteroid injections
Key exclusion criteria (5 listed)
- Pregnancy
- Patients who have had more than one corticosteroid injection in the last 6 months
- Patients with systemic inflammatory diseases
- Patients who have previously undergone surgery in the heel area
- Patients with a history of local trauma
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Plantar fascia thickness
Time frame: The thickness measurement will be evaluated immediately after the injection and 1 month after the injection.
Plantar fascia thickness measured by ultrasound
Pain score
Time frame: Pain will be assessed with a visual analog scale immediately after injection and 1 month later
Pain score assessed with a visual analog scale between 0 and 100
1 secondary outcome
Foot functions
Time frame: Foot functions will be assessed immediately after injection and 1 month after injection with the foot function index.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Jul 2025.
- Results publication''Yalıman A, Şen Eİ, Eskiyurt N, Budiman-Mak E. Ayak Fonksiyon İndeksi'nin Plantar Fasiitli Hastalarda Türkçe'ye Çeviri ve Adaptasyonu. Türk Fiz Tıp Rehab Derg 2014;60:212-22''
- Results publication: PubMed 32817771Aggarwal P, Jirankali V, Garg SK. Evaluation of plantar fascia using high-resolution ultrasonography in clinically diagnosed cases of plantar fasciitis. Pol J Radiol. 2020 Jul 24;85:e375-e380. doi: 10.5114/pjr.2020.97955. eCollection 2020.
- Results publication: PubMed 22619193McMillan AM, Landorf KB, Gilheany MF, Bird AR, Morrow AD, Menz HB. Ultrasound guided corticosteroid injection for plantar fasciitis: randomised controlled trial. BMJ. 2012 May 22;344:e3260. doi: 10.1136/bmj.e3260.
- Individual participant dataSharing planned: No
Related trials for Plantar Fasciitis
Not yet recruiting
Efficacy of TECAR Therapy in Plantar Fasciitis
Plantar Fasciitis
Not yet recruiting
Radial vs Focused Shockwave Therapy for Plantar Fasciitis
Plantar Fasciitis, Chronic
RecruitingObservational study
Tibial Nerve Size and Clinical Features in Chronic Plantar Fasciitis
Plantar Fasciitis, Chronic, Tibial Nerve
Recruiting
Video-Based Versus Physician-Led Exercise Training for Plantar Fasciitis
Plantar Fasciitis of Both Feet, Plantar Fascitis
Recruiting
Extracorporeal Shock Wave Therapy With or Without Kinesiotaping for Plantar Fasciitis
Plantar Fasciitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Mehmet Tekne, Resident Doctor principal investigator
Istanbul physical therapy rehabilitation training and research hospital
Nurdan Paker, Professor Doctor study director
Istanbul physical therapy rehabilitation training and research hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Plantar Fasciitis, run by Istanbul Physical Medicine Rehabilitation Training and Research Hospital at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 18 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Mehmet Tekne, Resident Doctor (+905415473323, mehmettekne23@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Plantar fascia thickness (time frame: The thickness measurement will be evaluated immediately after the injection and 1 month after the injection.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07057505, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jul 2025; AzTrials last refreshed its copy on 8 Nov 2026.